Transfersomes: a Revolutionary Nanosystem for Efficient Transdermal Drug Delivery
- PMID: 34853906
- DOI: 10.1208/s12249-021-02166-9
Transfersomes: a Revolutionary Nanosystem for Efficient Transdermal Drug Delivery
Abstract
Transdermal delivery system has gained significance in drug delivery owing to its advantages over the conventional delivery systems. However, the barriers of stratum corneum along with skin irritation are its major limitations. Various physical and chemical techniques have been employed to alleviate these impediments. Among all these, transfersomes have shown potential for overcoming the associated limitations and successfully delivering therapeutic agents into systemic circulation. These amphipathic vesicles are composed of phospholipids and edge activators. Along with providing elasticity, edge activator also affects the vesicular size and entrapment efficiency of transfersomes. The mechanism behind the enhanced permeation of transfersomes through the skin involves their deformability and osmotic gradient across the application site. Permeation enhancers can further enhance their permeability. Biocompatibility; capacity for carrying hydrophilic, lipophilic as well as high molecular weight therapeutics; deformability; lesser toxicity; enhanced permeability; and scalability along with potential for surface modification, active targeting, and controlled release render them ideal designs for efficient drug delivery. The current review provides a brief account of the discovery, advantages, composition, synthesis, comparison with other cutaneous nano-drug delivery systems, applications, and recent developments in this area.
Keywords: Cutaneous nano-drug delivery systems; Nanotechnology; Permeation enhancer; Transdermal drug delivery; Transfersomes.
© 2021. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
Similar articles
-
Overcoming Skin Barrier with Transfersomes: Opportunities, Challenges, and Applications.Curr Drug Deliv. 2025;22(2):160-180. doi: 10.2174/0115672018272012231213100535. Curr Drug Deliv. 2025. PMID: 38178667 Review.
-
Lipid vesicles: A versatile drug delivery platform for dermal and transdermal applications.Colloids Surf B Biointerfaces. 2020 Nov;195:111262. doi: 10.1016/j.colsurfb.2020.111262. Epub 2020 Jul 17. Colloids Surf B Biointerfaces. 2020. PMID: 32736123 Review.
-
Identifying Underlying Issues Related to the Inactive Excipients of Transfersomes based Drug Delivery System.Curr Pharm Des. 2021;27(7):971-980. doi: 10.2174/1381612826666201016144354. Curr Pharm Des. 2021. PMID: 33069192 Review.
-
Transfersomes: The Ultra-Deformable Carrier System for Non-Invasive Delivery of Drug.Curr Drug Deliv. 2021;18(4):408-420. doi: 10.2174/1567201817666200804105416. Curr Drug Deliv. 2021. PMID: 32753015 Review.
-
Transfersomes--a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation.Drug Dev Ind Pharm. 2003 Oct;29(9):1013-26. doi: 10.1081/ddc-120025458. Drug Dev Ind Pharm. 2003. PMID: 14606665
Cited by
-
Transfersomes: Recent Advances, Mechanisms, Exhaustive Applications, Clinical Trials, and Patents.Curr Drug Deliv. 2025;22(2):215-230. doi: 10.2174/0115672018295038240209055444. Curr Drug Deliv. 2025. PMID: 38385485 Review.
-
Lipid Nano-System Based Topical Drug Delivery for Management of Rheumatoid Arthritis: An Overview.Adv Pharm Bull. 2023 Nov;13(4):663-677. doi: 10.34172/apb.2023.075. Epub 2023 Apr 29. Adv Pharm Bull. 2023. PMID: 38022817 Free PMC article. Review.
-
Beneath the Skin: A Review of Current Trends and Future Prospects of Transdermal Drug Delivery Systems.Pharmaceutics. 2022 May 28;14(6):1152. doi: 10.3390/pharmaceutics14061152. Pharmaceutics. 2022. PMID: 35745725 Free PMC article. Review.
-
Nanoencapsulation of Tea Catechins for Enhancing Skin Absorption and Therapeutic Efficacy.AAPS PharmSciTech. 2022 Jul 8;23(6):187. doi: 10.1208/s12249-022-02344-3. AAPS PharmSciTech. 2022. PMID: 35798907 Review.
-
Strategies to Improve the Transdermal Delivery of Poorly Water-Soluble Non-Steroidal Anti-Inflammatory Drugs.Pharmaceutics. 2024 May 16;16(5):675. doi: 10.3390/pharmaceutics16050675. Pharmaceutics. 2024. PMID: 38794337 Free PMC article. Review.
References
-
- Thomas BJ, Finnin BC. The transdermal revolution. Drug Discovery Today. 2004;9(16):697–703. - PubMed
-
- Abd El-Alim SH, Kassem AA, Basha M, Salama A. Comparative study of liposomes, ethosomes and TFS as carriers for enhancing the transdermal delivery of diflunisal: in vitro and in vivo evaluation. Int J Pharm. 2019;563:293–303. - PubMed
-
- Marwah H, Garg T, Goyal AK, Rath G. Permeation enhancer strategies in transdermal drug delivery. Drug Delivery. 2016;23(2):564–78. - PubMed
-
- Dudhipala N, Phasha Mohammed R, Adel Ali Youssef A, Banala N. Effect of lipid and edge activator concentration on development of aceclofenac-loaded TFS gel for transdermal application: in vitro and ex vivo skin permeation. Drug development and industrial pharmacy. 2020;46(8):1334–44.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources